Long-term safety and efficacy of sepetaprost, with or without timolol, in patients with open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J2 study
Inatani M., Tone Y., Ikeda T., Angeles R.
Dedicated to scientific advancement and pioneering discoveries in ophthalmology
As a specialist with over 130 years of expertise, Santen is committed to continually investigating the latest in science and innovation to deliver the best vision experience.
About Publications PlusBrowse Publications
Therapeutic Area
Technology
Category
Latest Publications
Efficacy and safety of sepetaprost in patients with primary open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J1 study
Inatani M., Kanamori A., Inai M., Ikeda T., Angeles R.
Cost-Effectiveness Analysis of Low-Dose Atropine Eye Drops (0.01%) for the Treatment of Myopia in Children: A United Kingdom Perspective
Shi-van Wielink K., Dahlmann-Noor A., Li J., de Milliano T.W.L., Ernst F., Croci F., Sharma Y., Punekar Y.